Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies

Journal of Neuroimmunology

Volumn 219, Issue 1-2, 2010, Pages 119-122

  Nobile Orazio, Eduardo ^a,b   Giannotta, Claudia ^b   Briani, Chiara ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

CIDP; Ganglioside complex; GD1a; GM1; IgM; Multifocal motor neuropathy

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE GM1 ANTIBODY; GANGLIOSIDE GM2; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M ANTIBODY;

ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MOTOR NEURON DISEASE; MOTOR NEUROPATHY; POEMS SYNDROME; POLYNEUROPATHY; PRIORITY JOURNAL;

AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN M; MALE; MOTOR NEURON DISEASE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 77249086521     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.11.012     Document Type: Article

References (12)

1. Greeshields K.N., Halstead S.K., Zitma F.M.P., Rinaldi S., Brennam K.M., O'Leary C., Chamberlain L.H., Easton A., Roxburgh J., Pediani J., Furukawa K., Furukawa K., Goodyear C.S., Plomp J.J., Willison H.J. The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipids environment in mice. J. Clin. Invest. 2009, 119:595-609.
2. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. J. Periph. Nerv. Sys. 2005, 10:220-228. Joint Task Force of the EFNS and the PNS.
3. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. J. Periph. Nerv. Sys. 2006, 11:1-8. Joint Task Force of the EFNS and the PNS.
4. Kaida K., Morita D., Kanzaki M., Kamakura K., Motoyoshi K., Hirakawa M., Kusunoki S. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann. Neurol. 2004, 56:567-571.
5. Kaida K., Kanzaki M., Morita D., Kamakura K., Motoyoshi K., Hirakawa M., Kusunoki S. Anti-ganglioside complex antibodies in Miller Fisher syndrome. J. Neurol. Neurosurg. Psychiatry 2006, 77:1043-1046.
6. Kaida K., Morita D., Kanzaki M., Kamakura K., Motoyoshi K., Hirakawa M., Kusunoki S. Anti-ganglioside complex antibodies associated with severe disability in GBS. J. Neuroimmunol. 2007, 182:212-218.
7. Kaida K., Kamakura K., Ogawa G., Ueda M., Motoyoshi K., Arita M., Kusunoki S. GD1b specific antibody induces ataxia in Guillain-Barré syndrome. Neurology 2008, 71:196-201.
8. Kaida K., Sonoom M., Ogawa G., Kamakura K., Ueda-Sada M., Arita M., Motoyoshi K., Kusunoki S. GM1/GalNAc-GD1a complex. A target for pure motor Guillain-Barré syndrome. Neurology 2008, 71:1683-1690.
9. Nobile-Orazio E. Multifocal motor neuropathy. J. Neuroimmunol. 2001, 115:4-18.
10. Nobile-Orazio E., Gallia F., Terenghi F., Allaria S., Giannotta C., Carpo M. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?. J. Neurol. Sci. 2008, 266:156-163.
11. van Schaik I.N., Bossuyt P.M.M., Brand A., Vermeulen M. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis. Neurology 1995, 45:1570-1577.
12. Willison H. Ganglioside complexes: new autoantibody targets in Guillain-Barré syndromes. Nat. Clin. Pract. Neurol. 2005, 1:2-3.